原料辞典検索/acrylates-c10-30-alkyl-acrylate-crosspolymer/ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
Tier 1 Monograph · SSOT 15 FieldsRaw .md (GEO) ↗
合成 (Synthetic)

ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER

標準 INCI 準拠: ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
皮膜形成剤粘度調整剤乳化安定剤
[EU CosIng Official Definition] C10-30 alkyl propenoate, polymer with propenoic acid, butenoic acidand/or alkyl propenoates, product with propenyl sucrose ether or propenyl 2,2-dihydroxymethyl-1,3-propanediol
結論先行 エグゼクティブ規制・安全性ファクトボックスAEO / GEO CITATION ANCHOR

化粧品における ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER のグローバル配合基準と処方特性とは?

ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER(CAS番号: N/A)は、化粧品処方において主に皮膜形成剤, 粘度調整剤, 乳化安定剤として配合される原料です。日本厚労省/JCIA(規制なし)、韓国MFDS(規制なし)、欧州CosIng(規制なし)など6大法域の法定基準下で管理され、通常 0.1–0.8%(適正安定域 pH 5–9)で処方されます。

7大トラック 国別・用途別 公式全成分表示名称マトリクス

各国公的告示原典のみ収録 · 機械翻訳・任意音訳ゼロ
7-Track Official Statutory Label Names for ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
法域・規制トラック公式全成分表示名称ワンクリックコピー
① 韓国 (MFDS 化粧品標準名称)ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (KR MFDS Registered)
② 韓国旧名称履歴 (301 リダイレクト)——
③ 欧州連合 (EU CosIng EC 1223/2009)ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
④ 米国一般化粧品 (US PCPC / MoCRA INCI)ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
⑤ 米国 FDA OTC モノグラフ有効成分名— (米国 OTC 対象外 / 一般化粧品原料)—
⑥ 中国 (NMPA IECIC 標準中国語名称)丙烯酸(酯)类/C10-30 烷醇丙烯酸酯交联聚合物
⑦ 日本化粧品表示名称 / 医薬部外品外原規名称 (JCIA / MHLW)ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (標準INCI参照 · 任意カタカナ音訳排除)

Layer 1 — 6大法域 法定配合上限および規制ステータス

Layer 1 Statutory Regulatory Limits Across 6 Regions for ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
法域規制ステータス配合上限制限条件および一次法源出典
韓国 (MFDS)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
欧州 (EU)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
米国 (FDA)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
中国 (NMPA)規制なしGMPIECIC Entry #1423
日本 (MHLW)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)
ASEAN (ACD)規制なしGMP公的化粧品原料目録収載 (GMP基準内使用)

Layer 2 — 毒性・安全性評価上限 (US CIR / EU SCCS / CN IECIC)

「欧州 SCCS 安全性評価上限」は消費者安全科学委員会が安全域 (MoS≥100) と判定した毒性学的上限であり、「米国 CIR 市販製品最大報告濃度」および「中国 IECIC 最高歴史使用量」は市販製品における最大実績濃度です。

Layer 2 Toxicological & Historical Safe Use Concentrations for ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
安全性評価基準適用範囲・用途安全濃度範囲判定結果および文献参照
中国 IECIC 最高歴史使用量leave_on≤ 2.6%安全判定 (MoS≥100)NMPA IECIC (2025) Entry 01134 (2025)
中国 IECIC 最高歴史使用量rinse_off≤ 2%安全判定 (MoS≥100)NMPA IECIC (2025) Entry 01134 (2025)
⚠️ 参考用案内 (免責事項): 本辞典の成分名・規制上限・処方ガイドは研究開発の参考用です。法改正の時差やデータの誤記・漏れがあり得るため、実際の処方・ラベル表示・届出前には必ず管轄当局の最新告示原文をご確認ください。本情報の利用により生じた問題について運営主体は法的責任を負いません。
Interactive Quartile Box-Plot (Min–Q1–Median–Q3–Max)

Layer 3 Formulation Concentration Box-Plot vs. Statutory Limit

Aqueous Serum / Ampoulen=45
Min 0.1% · Q1 0.15% · Median 0.25% · Q3 0.35% · Max 0.8%
Emulsion / Creamn=118
Min 0.1% · Q1 0.15% · Median 0.2% · Q3 0.3% · Max 0.8%
Sunscreen / Colorn=10
Min 0.15% · Q1 0.2% · Median 0.25% · Q3 7.6% · Max 20%
Aqueous Serum / Ampoule — Hydrogel thickener & polymeric co-emulsifier
Verified Source: Lubrizol Pemulen TR-1/TR-2 TDS & CIR Assessment (cir_safety) · Lubrizol 24 · Evonik 14 · Colonial 7
Typical Median: 0.25%

Layer 3 — 剤形別通常配合濃度 (四分位数 n≥5) & 物理化学・相溶性ガイド

Layer 3 Formulation Concentration Quartiles by Product Category for ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER
剤形グループMin – Q1 – Median – Q3 – Max (%)処方役割・作用機序Source ID
剤形群 A — 水성化粧水・美容液・アンプル0.1% · 0.15% · 0.25% · 0.35% · 0.8%Hydrogel thickener & polymeric co-emulsifierLubrizol Pemulen TR-1/TR-2 TDS & CIR Assessment
剤形群 B — 乳液・エマルジョン・クリーム0.1% · 0.15% · 0.2% · 0.3% · 0.8%Surfactant-free polymeric primary/co-emulsifierLubrizol Pemulen TDS & CIR Reported Use
剤形群 D — 日焼け止め (UV)・メイクアップ・ファンデーション0.15% · 0.2% · 0.25% · 7.6% · 20%Sun care & color cosmetics dispersion / sensory modifierGlobal Starter Formulation Library Statistical Distribution (n=10, EVONIK 8 · GRANT 2)
Cutaneous Permeation Science (500 Dalton Rule)MW: Macro/Complex · LogP: N/A

Stratum Corneum Penetration Depth & Bio-Spicule Transdermal Delivery

Stratum Corneum (Brick & Mortar Barrier · 10–20 µm)500 Da Molecular Weight Cutoff BarrierViable Epidermis (Keratinocytes & Melanocytes · 50–100 µm)Target for Brightening (Tyrosinase/Melanosome) & Barrier LipidsPapillary Dermis (Fibroblasts & ECM Collagen · 150–300 µm)Target for Collagen I/III Synthesis, Peptides, PDRN & ExosomesEpidermal Passive Permeation (<500 Da)
Molecular Weight & LogP Permeation Diagnosis
Low Molecular Weight (320 Da ≤ 500 Da) — Passive Permeation Feasible

Under passive topical application, molecules diffuse tortuously through intercellular lipids. Hydrophilic compounds >500 Da remain primarily on the outer stratum corneum.

Estimated Target Depth
40–90 µm
Optimal Delivery System
Polyol Enhancer / Serum
Colloid Interface, pH Spectrum & Thermal Stability

pH Stability Window (0–14), Thermal Limit & HLB Colloidal Phase Behavior

Dispersible in water or oil phase prior to neutralization
Optimal Formulation pH Stability Window (0–14)pH 5.0 – 9.0
0245.5791114

Outside pH 5–9, risk of hydrolysis, viscosity loss, or ionic dissociation increases.

Maximum Thermal Processing Limit (°C)≤ 80°C
25°C45°C60°C75°C85°C100°C

Thermally stable up to 80°C during standard emulsification.

HLB Scale (0–20) & Colloidal Micelle / Lamellar Phase Simulator
O/W Oil-in-Water Micelle Emulsion (Lotion / Cream)
HLB 11.5
W/O (3–6)Lamellar (8–10.5)O/W Emulsion (11–15)Solubilizer (15–19)O/W Droplet
Biochemical Signaling & Mechanism Pathway

Cellular & Molecular Target Mechanism Flow

1. Epidermal Interaction→ Upregulation / Activation
Intercellular Lipid & Hydration Matrix
→
TEWL Reduction & Barrier Conditioning
2. Homeostasis Modulation⊣ Inhibition / Blockade
Oxidative Stress (ROS) & Irritant Cascade
⊣
Cutaneous Soothing & Homeostasis
Formulation Ontology Radial Graph

Interactive Synergy Pairings (Solid) & Incompatibility Warnings (Dashed)

+ TROMETHAMINE+ ARGININE+ CAPRYLIC/CAPRIC TR…✕ Viscosity loss at pH…✕ Incompatible with ca…ACRYLATES/C10-30 A…
Interactive Node Guide

Click any green synergy node to jump directly to its monograph, or click a red dashed node to inspect the chemical incompatibility mechanism.

代表商品名参考 (商標法第90条第1項第2号 記述的表示)
Pemulen™ TR-1Pemulen™ TR-2Carbopol® Ultrez 20Carbopol® Ultrez 30

商品名は研究者がグレードを識別するための参考表記であり、各商標権は原メーカーに帰属します。

学術・毒性・処方統合モノグラフ

Tier 1 Synthesis

本原料に紐づく NIH PubMed 査読付き論文アブストラクトおよび公的毒性評価報告書のみに基づいて作成された学術要約です。

■ [1. Chemical Identity & International Labeling Nomenclature] - INCI Name: ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER | CAS No.: N/A | EC No.: N/A - Origin: SYNTHETIC | Functions: , , - Physicochemical Profile: Formula | MW /(Polymer/Complex) | / | Ionic Nature: anionic | CosIng/MFDS - Official Regional Label Names: US [ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER] · EU [ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER] · CN [丙烯酸(酯)类/C10-30 烷醇丙烯酸酯交联聚合物] · JP [-] · JP Quasi-Drug [-] ■ [2. Dermatological Mechanism of Action & Functional Role] - C10-30 alkyl propenoate, polymer with propenoic acid, butenoic acidand/or alkyl propenoates, product with propenyl sucrose ether or propenyl 2,2-dihydroxymethyl-1,3-propanediol Classified under origin 'synthetic', it acts within the cosmetic vehicle or stratum corneum to deliver , , performance and structural formulation stability. ■ [3. Global 6-Jurisdiction Regulatory Status & Safety Limits (Layer 1 & Layer 2)] - Regional Summary: KR: NONE | EU: NONE | US: NONE | CN: NONE | JP: NONE | ASEAN: NONE (CN IECIC (2025) Entry No. 1423 (丙烯酸(酯)类/C10-30 烷醇丙烯酸酯交联聚合物)) - No specific Annex prohibition or numeric restriction across the 6 major jurisdictions (Permitted under general GMP safety assessment). - Official Safety & Historical Use Concentration (Layer 2): CN_IECIC_2025 (cn_iecic_max, leave_on): Max 2.6% / CN_IECIC_2025 (cn_iecic_max, rinse_off): Max 2.0% ■ [4. Formulation Dosage Guide by Product Category (Layer 3-A)] - [aqueous_serum] Typical range: 0.1 ~ 0.8% (Median 0.25%, Ref: Lubrizol Pemulen TR-1/TR-2 TDS & CIR Assessment) — Hydrogel thickener & polymeric co-emulsifier - [emulsion_cream] Typical range: 0.1 ~ 0.8% (Median 0.2%, Ref: Lubrizol Pemulen TDS & CIR Reported Use) — Surfactant-free polymeric primary/co-emulsifier - [sun_color] Typical range: 0.15 ~ 20.0% (Median 0.25%, Ref: Global Starter Formulation Library Statistical Distribution (n=10, EVONIK 8 · GRANT 2)) — Sun care & color cosmetics dispersion / sensory modifier ■ [5. Formulation Engineering, Stability & Incompatibility Matrix (Layer 3-B)] - Addition Phase: Water or Oil Phase (Direct addition prior to neutralization) - Optimal pH Range: pH 5.0 ~ 9.0 | Max Process Temp: Max 80°C | Electrolyte Tolerance: MEDIUM - Incompatibility / Caution: Viscosity loss at pH < 4.5 or high multivalent electrolyte levels - Incompatibility / Caution: Incompatible with cationic conditioning agents - Synergy Pairings: TROMETHAMINE, ARGININE, CAPRYLIC/CAPRIC TRIGLYCERIDE | Reference Trade Names: Pemulen™ TR-1, Pemulen™ TR-2, Carbopol® Ultrez 20, Carbopol® Ultrez 30 ■ [6. Peer-Reviewed Literature & Official Compendia Evidence] - PMID 39187930 (2024, Contact Dermatitis): Sensitisation to the acrylate co-polymers glyceryl acrylate/acrylic acid co-polymer, sodium polyacrylate and acrylates/C - PMID 24575934 (2014, Int J Cosmet Sci): Texture analysis of cosmetic/pharmaceutical raw materials and formulations - PMID 19398245 (2009, Am J Infect Control): Inactivation of chlorhexidine gluconate on skin by incompatible alcohol hand sanitizing gels

関連査読付き学術論文 (NIH PubMed) (3)

Sensitisation to the acrylate co-polymers glyceryl acrylate/acrylic acid co-polymer, sodium polyacrylate and acrylates/C10-30 alkyl acrylate cross-polymer (Carbopol®) is rare [PMID: 39187930 · 2024]
Soriano LF, Chowdhury MMU, Cousen P, Dawe S, Ghaffar SA, Haworth A, Holden CR, Hollywood A, Johnston GA, Kirk S, Mughal AA, Orton DI, Parker R, Rajeev A, Scharrer K, Sinha A, Stone NM, Thompson D, Wakelin S, Whitehouse H, Wootton C, Buckley DA · Contact Dermatitis (2024)

Acrylate polymers and cross-polymers (ACPs) are frequently used cosmetic ingredients. The British Society for Cutaneous Allergy (BSCA) and the UK Cosmetic, Toiletry and Perfumery Association (CTPA) collaborated to investigate the allergenic potential of three commonly-used ACPs. The objective of this study is to determine the prevalence of allergic contact dermatitis (ACD) to three ACPs: glyceryl acrylate/acrylic acid co-polymer, sodium polyacrylate, and acrylates/C10-30 alkyl acrylate cross-polymer (Carbopol&#xae;). The BSCA prospectively audited data collected from 20 centres in the UK and Ireland between 1st September 2021 and 1st September 2022. Patients with suspected ACD to (meth)acrylates, with facial dermatitis, or consecutive patients, were patch tested to glyceryl acrylate/acrylic acid co-polymer 10% aqueous (aq.) sodium polyacrylate 2% aq., and to acrylates/C10-30 alkyl acrylate cross-polymer 2% aq. (Carbopol&#xae;). The frequencies of positive, irritant, and doubtful reactions were recorded. In total, 1302 patients were patch tested. To glyceryl acrylate/acrylic acid co-polymer, there was one doubtful reaction in a patient allergic to multiple (meth)acrylates, and one irritant. To sodium polyacrylate, there were four irritant reactions, one doubtful, and one positive reaction; in all cases, relevance was unknown and there was no demonstrable (meth)acrylate allergy. There were no reactions to Carbopol&#xae;. Sensitisation to these concentrations of the three tested ACPs is rare. Elicitation of dermatitis in (meth)acrylate-sensitised patients by exposure to these three ACPs appears unlikely.

Texture analysis of cosmetic/pharmaceutical raw materials and formulations [PMID: 24575934 · 2014]
Tai A, Bianchini R, Jachowicz J · Int J Cosmet Sci (2014)

The purpose of this work was to quantify textural properties of cosmetic and pharmaceutical raw materials. Textural parameters such as hardness, consistency, cohesiveness, index of viscosity, stickiness and resilience were evaluated. The measurements were performed using texture analyser - a tensile metre equipped with special probes (in the form of acrylic cylinder and stainless steel sphere), which can penetrate the measured sample of a product recording the force, distance and time. The instrument simulates the action of a human finger touching the surface and probing the properties of an object. The set-up has been previously shown to quantify the rheological/textural properties of cosmetic and pharmaceutical products such as creams, lotion and gels as well as rheological behaviour of human skin. The results include the analysis of water, glycerine and mineral oil as well as aqueous solutions of thickeners such as Acrylates/C10-30 Alkyl Acrylate Crosspolymer (Ultrez-20 obtained from Noveon) and carbomer. Solutions of common surfactants and complex surfactant formulations such as shampoos have also been investigated. The results, in the form plots of force as a function of time or distance, resulting from slow bidirectional probe movement (submergence and desubmergence) in the analysed fluid, were interpreted by considering buoyancy, drag and viscous drag force given by Stokes equation. The data can be used to correlate with tactile evaluations of products by trained panel evaluations.

Inactivation of chlorhexidine gluconate on skin by incompatible alcohol hand sanitizing gels [PMID: 19398245 · 2009]
Kaiser N, Klein D, Karanja P, Greten Z, Newman J · Am J Infect Control (2009)

Incompatibility of leave-on products with an antimicrobial residual can negate the efficacy benefits of chlorhexidine gluconate (CHG) persistence. Two marketed alcohol products containing Carbomer were tested using a pigskin substrate model against Staphylococcus aureus. The CHG residual achieved a 4.22 log(10) reduction (standard deviation [SD] = 0.32) in this study, which was dramatically reduced to a 0.54 (SD = 0.50) and 0.46 (SD = 0.56) after subsequent treatment with incompatible alcohol gel products. A marketed alcohol product containing a nonionic thickener maintained the efficacy of the CHG chemical reservoir (log(10) reduction = 4.26, SD = 0.00). Similar findings were demonstrated when alcohol solutions containing the individual thickening agents were tested as simple formulations. An in vivo test using human forearms and Serratia marcescens similarly demonstrated that the activity of a CHG reservoir (log(10) reduction = 3.73, SD = 0.86) was not reduced by a nonionic thickened product (log(10) reduction = 3.98, SD = 0.72) but was significantly reduced by treatment with alcohol products containing anionic thickeners carbomer (log(10) reduction = -0.32, SD = 0.34) or acrylates/C10-30 alkyl acrylate crosspolymer (log(10) reduction = -0.20, SD = 0.32). The use of anionic thickeners or emulsifiers in leave-on products, including alcohol hand sanitizers, may inactivate the persistent antibacterial activity of CHG.

よくある質問 (FAQ)

Q1. ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER の各国公式全成分表示名称(7トラック)はどのように異なりますか?
日本化粧品工業連合会(JCIA)表示名称は 'ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (標準INCI準拠)'、米国PCPC・欧州CosIng INCIは 'ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER'、中国NMPA IECIC標準中国語名は '丙烯酸(酯)类/C10-30 烷醇丙烯酸酯交联聚合物' です。
Q2. ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER のグローバル6大法域における法定配合基準 (Layer 1) は?
6大法域規制ステータス — 日本(JP): none、韓国(KR): none、欧州(EU): none、米国(US): none、中国(CN): none、ASEAN: none。
Q3. 処方設計における ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER の通常配合濃度 (Layer 3) と適正 pH は?
主要剤形 (aqueous_serum) において通常 0.1〜0.8%(中央値 0.25%)で配合され、適正pH範囲は 5〜9 です。
Q4. ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER の配合禁忌 (Incompatibilities) と推奨シナジー成分は?
推奨シナジーペアは TROMETHAMINE, ARGININE, CAPRYLIC/CAPRIC TRIGLYCERIDE、配合上の注意点は Viscosity loss at pH < 4.5 or high multivalent electrolyte levels; Incompatible with cationic conditioning agents です。